ArticleArthritis research & therapy2022

Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study.

Ippei Miyagawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.